Skip to main content
Clinical Trials/JPRN-UMIN000010853
JPRN-UMIN000010853
Completed
Phase 2

A prospective study to validate the efficacy on the induction, consolidation, and maintenance therapy for the elderly multiple myeloma patients. - Teikyo elderly MM study

niversity of Teikyo School of Medicine, Internal medicine, department of Hematology/Oncology0 sites24 target enrollmentJune 1, 2013

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Multiple myeloma patients over the age of 70.
Sponsor
niversity of Teikyo School of Medicine, Internal medicine, department of Hematology/Oncology
Enrollment
24
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 1, 2013
End Date
March 30, 2016
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Teikyo School of Medicine, Internal medicine, department of Hematology/Oncology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who are not eligible for this study are: 1\. may be pregnant or are pregnant. 2\. suffered from an active cancer within the last five years. 3\. HBs antigen positive, HCV\-antibody positive, HIV\-antibody positive 4\. severe psychometric dysfunction 5\. with interstitial pneumonitis 6\. with a severe active infection 7\. with a severe pulmonary dysfunction; PaO2/FiO2 ratio \<200 8\. with a severe cardiac dysfunction; percent fractional shortening \<15% 9\. judged unsuitable by the doctor 10\. cannot take an oral administration.

Outcomes

Primary Outcomes

Not specified

Similar Trials